High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice
BMJ2011Vol. 342(jun21 1), pp. d3514–d3514
Citations Over TimeTop 1% of 2011 papers
Abstract
Almost 14% of patients defined as particularly vulnerable to adverse drug events were prescribed one or more high risk drugs. The composite indicator of high risk prescribing used could identify practices as having above average or below average high risk prescribing rates with reasonable confidence. After adjustment, only the number of drugs prescribed long term to patients was strongly associated with high risk prescribing, and considerable unexplained variation existed between practices. High risk prescribing will often be appropriate, but the large variation between practices suggests opportunities for improvement.
Related Papers
- → Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade☆(2010)65 cited
- → Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast(1994)17 cited
- → Is Breast Cancer Ever Cured? Follow-Up Study of 5623 Breast Cancer Patients(1991)4 cited
- The expression of insulin-like growth factor-1 receptor on LN ( - )breast cancer,LN( + )breast cancer and normal breast tissue(2004)
- → MRI of male breast carcinoma(2020)